University of Adelaide
A combined lipophilic prodrug and lipid-based drug delivery approach to enable oral chemotherapy (with SN38)
Abstract
dc:description.abstractThe current project is focused on enabling the oral delivery of a challenging, but highly potent compound against CRC, 7-ethyl-10-hydroxycamptothecin (SN38), using nanomedicine and/or prodrug approaches. In particular, the thesis describes (i) the fabrication of a silica-lipid hybrid (SLH) delivery systems for SN38, with high drug loading by drug-surfactant complexation and determination of its in vitro and in vivo performance; (ii) the synthesis, characterisation and lead selection of lipophilic prodrugs for SN38; and (iii) the development of a lipid-based oral delivery system for the lead lipophilic SN38 prodrug.
Degree
thesis:*- College dc:contributor.school
- University of South Australia. School of Pharmacy and Medical Sciences.
- Year dc:date.issued
- 2016
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Bala, Vaskor
Subjects
dc:subject × 3Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/11541.2/123748